Critical and Distinct Roles of Cell Type-specific NF-κB2 in Lung Cancer
Overview
General Medicine
Affiliations
Different from the well-studied canonical NF-κB member RelA, the role of the noncanonical NF-κB member NF-κB2 in solid tumors, and lung cancer in particular, is poorly understood. Here we report that in contrast to the tumor-promoting role of RelA, NF-κB2 intrinsic to lung epithelial and tumor cells had no marked effect on lung tumorigenesis and progression. On the other hand, NF-κB2 limited dendritic cell number and activation in the lung but protected lung macrophages and drove them to promote lung cancer through controlling activation of noncanonical and canonical NF-κB, respectively. NF-κB2 was also required for B cell maintenance and T cell activation. The antitumor activity of lymphocyte NF-κB2 was dominated by the protumor function of myeloid NF-κB2; thus, NF-κB2 has an overall tumor-promoting activity. These studies reveal a cell type-dependent role for NF-κB2 in lung cancer and help understand the complexity of NF-κB action and lung cancer pathogenesis for better design of NF-κB-targeted therapy against this deadliest cancer.
Song X, Qu Z PLoS One. 2024; 19(5):e0303138.
PMID: 38722890 PMC: 11081228. DOI: 10.1371/journal.pone.0303138.
NF-κB RelA is a cell-intrinsic metabolic checkpoint restricting glycolysis.
Li L, Han L, Qu Z Cell Biosci. 2024; 14(1):11.
PMID: 38245770 PMC: 10799406. DOI: 10.1186/s13578-024-01196-7.